Ares Acquisition Corp II Financials

Ares Acquisition Corp II (AACT) reported $3.8M in total revenue for fiscal year 2025. This represents a -74.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Ares Acquisition Corp II (AACT) revenue declined by 74.6% year-over-year, from $14.9M to $3.8M in fiscal year 2025.

No, Ares Acquisition Corp II (AACT) reported a net income of -$585.5M in fiscal year 2025, with a net profit margin of -15420.7%.

Ares Acquisition Corp II (AACT) reported diluted earnings per share of $-6.42 for fiscal year 2025. This represents a -439.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ares Acquisition Corp II (AACT) had EBITDA of -$109.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Ares Acquisition Corp II (AACT) had $50.8M in cash and equivalents against $29.9M in long-term debt.

Ares Acquisition Corp II (AACT) had an operating margin of -2966.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Ares Acquisition Corp II (AACT) had a net profit margin of -15420.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Ares Acquisition Corp II (AACT) generated -$116.5M in free cash flow during fiscal year 2025. This represents a -115.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Ares Acquisition Corp II (AACT) generated -$94.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Ares Acquisition Corp II (AACT) had $159.4M in total assets as of fiscal year 2025, including both current and long-term assets.

Ares Acquisition Corp II (AACT) invested $22.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Ares Acquisition Corp II (AACT) invested $50.2M in research and development during fiscal year 2025.

Ares Acquisition Corp II (AACT) had 175M shares outstanding as of fiscal year 2025.

Ares Acquisition Corp II (AACT) had a current ratio of 4.73 as of fiscal year 2025, which is generally considered healthy.

Ares Acquisition Corp II (AACT) had a debt-to-equity ratio of -0.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Ares Acquisition Corp II (AACT) had a return on assets of -367.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Ares Acquisition Corp II (AACT) had $50.8M in cash against an annual operating cash burn of $94.4M. This gives an estimated cash runway of approximately 6 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Ares Acquisition Corp II (AACT) has negative shareholder equity of -$283.1M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Ares Acquisition Corp II (AACT) has an Altman Z-Score of -8.26, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Ares Acquisition Corp II (AACT) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Ares Acquisition Corp II (AACT) has an earnings quality ratio of 0.16x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Ares Acquisition Corp II (AACT) has an interest coverage ratio of -27.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Ares Acquisition Corp II (AACT) scores 27 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.